TietoEVRY (TIETOS) Investor Presentation summary

Financial performance and targets

• Revenue for the last twelve months (LTM) Q3 2025 was €1,860 million, with adjusted EBITA of €240 million and a margin of 12.9%.

• Growth target is set at a CAGR of over 5% for 2027-2028, with profitability (adj. EBITA) above 16% by 2028.

• Dividend distribution is planned at 60-80% of net profit, with net debt/EBITDA targeted below 2x.

• Each business segment has specific growth and profitability targets, with Caretech aiming for >7% growth and >28% EBITA margin, and Banktech for >6% growth and >18% EBITA margin.

• Cost optimization program aims for €115 million in run-rate savings by end of 2026.

Strategic priorities and execution

• Four strategic priorities: customer first, simplified core, selective expansion, and competitive cost base.

• Focus on deepening customer relationships, expanding in the Nordics and selected European markets, and building distinctive capabilities in AI and software.

• Selective international expansion targets over €500 million in total contract value from Europe by 2028.

• Investment focus on strengthening the product portfolio, AI technologies, and aiming for shorter payback times and higher returns.

• Leverage target (net debt/EBITDA) to be reached by 2026, with excess capital distributed to shareholders.

Business segment highlights

• Tech Consulting targets >3% CAGR and >12% EBITA margin, focusing on AI, cloud, and data-driven growth.

• Banktech leverages Nordic leadership to expand in Europe, transitioning to a scalable SaaS portfolio and targeting >6% CAGR and >18% EBITA margin.

• Caretech leads with its Lifecare software, aiming for >7% CAGR and >28% EBITA margin, expanding through partner-led go-to-market strategies in Europe.

• Indtech focuses on scalable software for selected European markets, with >6% CAGR and >17% EBITA margin targets, and a strong position in the Nordics.